Skip to main content

Question for Department of Health and Social Care

UIN 9559, tabled on 16 October 2024

To ask the Secretary of State for Health and Social Care, if his Department will (a) review evidence on the health impacts of Primodos and (b) make an assessment of the potential merits of introducing a financial redress scheme for people affected by Primodos.

This answer is the replacement for a previous holding answer.

Answered on

23 October 2024

We are hugely sympathetic to the families who believe that they have suffered because of using Hormone Pregnancy Tests (HPTs). Currently, the available scientific evidence does not support a causal association between the use HPTs during early pregnancy and adverse pregnancy outcomes.

The Medicines and Healthcare products Regulatory Agency, together with the wider Government, has committed to review any new scientific evidence which comes to light since the conclusions of the 2017 independent Expert Working Group convened by the Commission on Human Medicines.

Due to the unavailability of scientific evidence supporting a causal association between the use of HPTs and adverse pregnancy outcomes, options for financial redress have not been considered further.

Named day
Named day questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.